DSGN
Design Therapeutics Inc
Price:  
6.62 
USD
Volume:  
150,711.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DSGN WACC - Weighted Average Cost of Capital

The WACC of Design Therapeutics Inc (DSGN) is 6.8%.

The Cost of Equity of Design Therapeutics Inc (DSGN) is 9.75%.
The Cost of Debt of Design Therapeutics Inc (DSGN) is 5.00%.

Range Selected
Cost of equity 8.20% - 11.30% 9.75%
Tax rate 22.10% - 22.30% 22.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.0% - 7.6% 6.8%
WACC

DSGN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.93 1.14
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.20% 11.30%
Tax rate 22.10% 22.30%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.0% 7.6%
Selected WACC 6.8%